ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) shares dropped 3.9% on Monday . The company traded as low as $0.52 and last traded at $0.58. Approximately 3,965,537 shares traded hands during trading, an increase of 19,409% from the average daily volume of 20,327 shares. The stock had previously closed at $0.60.
ImmunoPrecise Antibodies Stock Performance
The firm has a fifty day moving average price of $0.45 and a two-hundred day moving average price of $0.59.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Read More
- Five stocks we like better than ImmunoPrecise Antibodies
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 3 Steel Stocks Soaring After Tariff Announcements
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
